

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.41119000 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.41119000 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.05985229 |
| 4 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.87420619 |
| 5 | COPII vesicle coating (GO:0048208) | 3.70592517 |
| 6 | protein retention in ER lumen (GO:0006621) | 3.64230650 |
| 7 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61430553 |
| 8 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.47221445 |
| 9 | protein localization to endosome (GO:0036010) | 3.44152759 |
| 10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.43102090 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36129910 |
| 12 | positive regulation of nuclease activity (GO:0032075) | 3.32425046 |
| 13 | vesicle coating (GO:0006901) | 3.30097851 |
| 14 | mannose metabolic process (GO:0006013) | 3.26481836 |
| 15 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.19256907 |
| 16 | skin morphogenesis (GO:0043589) | 3.14860919 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.14220365 |
| 18 | pinocytosis (GO:0006907) | 3.11940582 |
| 19 | ER-nucleus signaling pathway (GO:0006984) | 2.99625397 |
| 20 | cellular response to unfolded protein (GO:0034620) | 2.98940710 |
| 21 | regulation of nuclease activity (GO:0032069) | 2.98767363 |
| 22 | proline biosynthetic process (GO:0006561) | 2.88160371 |
| 23 | protein maturation by protein folding (GO:0022417) | 2.85065735 |
| 24 | regulation of histone H3-K27 methylation (GO:0061085) | 2.84970552 |
| 25 | regulation of cholesterol homeostasis (GO:2000188) | 2.80914650 |
| 26 | cellular response to topologically incorrect protein (GO:0035967) | 2.74274090 |
| 27 | regulation of early endosome to late endosome transport (GO:2000641) | 2.66603658 |
| 28 | embryonic process involved in female pregnancy (GO:0060136) | 2.65320069 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59753113 |
| 30 | regulation of extracellular matrix disassembly (GO:0010715) | 2.59409064 |
| 31 | pentose-phosphate shunt (GO:0006098) | 2.58588102 |
| 32 | NIK/NF-kappaB signaling (GO:0038061) | 2.57619810 |
| 33 | stress fiber assembly (GO:0043149) | 2.55991169 |
| 34 | response to endoplasmic reticulum stress (GO:0034976) | 2.51187412 |
| 35 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.49698081 |
| 36 | basement membrane organization (GO:0071711) | 2.49238464 |
| 37 | response to laminar fluid shear stress (GO:0034616) | 2.46938411 |
| 38 | cell-substrate junction assembly (GO:0007044) | 2.46696669 |
| 39 | hypotonic response (GO:0006971) | 2.44867348 |
| 40 | barbed-end actin filament capping (GO:0051016) | 2.44462491 |
| 41 | glucose 6-phosphate metabolic process (GO:0051156) | 2.43603692 |
| 42 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42894604 |
| 43 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.41620815 |
| 44 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.39730802 |
| 45 | positive regulation of extracellular matrix organization (GO:1903055) | 2.39688256 |
| 46 | desmosome organization (GO:0002934) | 2.39243310 |
| 47 | maternal placenta development (GO:0001893) | 2.39020269 |
| 48 | negative regulation of cell size (GO:0045792) | 2.38916151 |
| 49 | hemidesmosome assembly (GO:0031581) | 2.38146716 |
| 50 | iron ion import (GO:0097286) | 2.36750425 |
| 51 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.35793722 |
| 52 | response to peptidoglycan (GO:0032494) | 2.34925482 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.34668785 |
| 54 | ER overload response (GO:0006983) | 2.33646121 |
| 55 | negative regulation of cell killing (GO:0031342) | 2.33429578 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.33429578 |
| 57 | hyaluronan catabolic process (GO:0030214) | 2.32006075 |
| 58 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.31226381 |
| 59 | glucose catabolic process (GO:0006007) | 2.29947978 |
| 60 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.28534155 |
| 61 | cellular response to interleukin-4 (GO:0071353) | 2.28292892 |
| 62 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.27230446 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.26703062 |
| 64 | NADH metabolic process (GO:0006734) | 2.26635452 |
| 65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.25456270 |
| 66 | response to muramyl dipeptide (GO:0032495) | 2.24765189 |
| 67 | modulation by symbiont of host cellular process (GO:0044068) | 2.24716630 |
| 68 | response to thyroid hormone (GO:0097066) | 2.24080474 |
| 69 | regulation of defense response to virus by virus (GO:0050690) | 2.22170167 |
| 70 | cell-substrate adherens junction assembly (GO:0007045) | 2.21281542 |
| 71 | focal adhesion assembly (GO:0048041) | 2.21281542 |
| 72 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.20996174 |
| 73 | response to unfolded protein (GO:0006986) | 2.20288602 |
| 74 | protein carboxylation (GO:0018214) | 2.19784992 |
| 75 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.19784992 |
| 76 | membrane raft organization (GO:0031579) | 2.19061089 |
| 77 | peptidyl-proline hydroxylation (GO:0019511) | 2.18297028 |
| 78 | negative regulation of necroptotic process (GO:0060546) | 2.17763709 |
| 79 | activation of Rac GTPase activity (GO:0032863) | 2.17049923 |
| 80 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.16389115 |
| 81 | detection of bacterium (GO:0016045) | 2.15916106 |
| 82 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.15832878 |
| 83 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.15454844 |
| 84 | glycosphingolipid catabolic process (GO:0046479) | 2.15422562 |
| 85 | protein hydroxylation (GO:0018126) | 2.14851666 |
| 86 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.13779159 |
| 87 | glycolipid catabolic process (GO:0019377) | 2.12652180 |
| 88 | cell adhesion mediated by integrin (GO:0033627) | 2.11749553 |
| 89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.11467689 |
| 90 | oxaloacetate metabolic process (GO:0006107) | 2.10411234 |
| 91 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.10283797 |
| 92 | regulation of necroptotic process (GO:0060544) | 2.10282408 |
| 93 | detection of other organism (GO:0098543) | 2.09944250 |
| 94 | negative regulation of fatty acid transport (GO:2000192) | 2.09927641 |
| 95 | NADPH regeneration (GO:0006740) | 2.09176687 |
| 96 | negative regulation of fibrinolysis (GO:0051918) | 2.08771465 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.08637779 |
| 98 | membrane protein ectodomain proteolysis (GO:0006509) | 2.07802540 |
| 99 | maintenance of protein localization in organelle (GO:0072595) | 2.07041310 |
| 100 | germinal center formation (GO:0002467) | 2.06915330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27702675 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.79124725 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.57369730 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57282160 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47278450 |
| 6 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.38366535 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28440730 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25830954 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06252064 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.03263556 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98674314 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93664938 |
| 13 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.90473228 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.89307418 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.88780471 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.88419005 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.87971522 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82542666 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80235715 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74996982 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.74664539 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71930651 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71491649 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.69412523 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 1.67897967 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64364247 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61252667 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58171172 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56150067 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53341766 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51623766 |
| 32 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51433294 |
| 33 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.49665455 |
| 34 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47498990 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46727459 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45984971 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.44576965 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42506464 |
| 39 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41996260 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40425272 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40206751 |
| 42 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40060225 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.37264399 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36842579 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36659455 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34898963 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32786525 |
| 48 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32299796 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31968139 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.31792925 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.31388913 |
| 52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.30247905 |
| 53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29551999 |
| 54 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.26777193 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25628603 |
| 56 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.25368279 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24866647 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24057962 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21986179 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21890956 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21029734 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20648554 |
| 63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20513735 |
| 64 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19764991 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19090172 |
| 66 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17954842 |
| 67 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17181495 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14843523 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14435625 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14067767 |
| 71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13378276 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12627215 |
| 73 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10756634 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08712253 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08563040 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.07614328 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07397606 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.07130692 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06859650 |
| 80 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06809272 |
| 81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06644223 |
| 82 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04207639 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04053018 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03669747 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03213762 |
| 86 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.02562126 |
| 87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02102147 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00855881 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00616932 |
| 90 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00589270 |
| 91 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00397546 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99769198 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99515699 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99515699 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98560127 |
| 96 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98024600 |
| 97 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97754769 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97588994 |
| 99 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96568710 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96331226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.23228293 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.12999775 |
| 3 | MP0005451_abnormal_body_composition | 2.89687938 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.78099212 |
| 5 | MP0003436_decreased_susceptibility_to | 2.77653194 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.75770506 |
| 7 | MP0009840_abnormal_foam_cell | 2.74061608 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.56586679 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.36070635 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 1.94515450 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 1.83385836 |
| 12 | MP0003303_peritoneal_inflammation | 1.83373372 |
| 13 | MP0004947_skin_inflammation | 1.82750232 |
| 14 | MP0008260_abnormal_autophagy | 1.82458150 |
| 15 | MP0003172_abnormal_lysosome_physiology | 1.73453022 |
| 16 | MP0000685_abnormal_immune_system | 1.67908896 |
| 17 | MP0005464_abnormal_platelet_physiology | 1.66804304 |
| 18 | MP0003763_abnormal_thymus_physiology | 1.65760108 |
| 19 | MP0000858_altered_metastatic_potential | 1.60631529 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.51992069 |
| 21 | MP0004233_abnormal_muscle_weight | 1.50631471 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.49276765 |
| 23 | MP0002060_abnormal_skin_morphology | 1.48907751 |
| 24 | MP0003091_abnormal_cell_migration | 1.48817746 |
| 25 | MP0005000_abnormal_immune_tolerance | 1.48809854 |
| 26 | MP0005023_abnormal_wound_healing | 1.46777509 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.46513917 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.45306953 |
| 29 | MP0005025_abnormal_response_to | 1.37298836 |
| 30 | MP0002419_abnormal_innate_immunity | 1.35569149 |
| 31 | MP0003453_abnormal_keratinocyte_physiol | 1.34428512 |
| 32 | MP0003279_aneurysm | 1.34257935 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.32116096 |
| 34 | MP0001790_abnormal_immune_system | 1.31153494 |
| 35 | MP0005387_immune_system_phenotype | 1.31153494 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.28622802 |
| 37 | MP0004272_abnormal_basement_membrane | 1.27917979 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.27496611 |
| 39 | MP0001958_emphysema | 1.27325789 |
| 40 | MP0005275_abnormal_skin_tensile | 1.27272212 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.22527745 |
| 42 | MP0002796_impaired_skin_barrier | 1.22435077 |
| 43 | MP0001849_ear_inflammation | 1.21031249 |
| 44 | MP0010352_gastrointestinal_tract_polyps | 1.18496985 |
| 45 | MP0001873_stomach_inflammation | 1.16731462 |
| 46 | MP0005257_abnormal_intraocular_pressure | 1.16235849 |
| 47 | MP0009785_altered_susceptibility_to | 1.16017121 |
| 48 | MP0003724_increased_susceptibility_to | 1.12025646 |
| 49 | MP0004510_myositis | 1.11164205 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.10265689 |
| 51 | MP0001348_abnormal_lacrimal_gland | 1.09973243 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.09842265 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.09720760 |
| 54 | MP0001800_abnormal_humoral_immune | 1.09510251 |
| 55 | MP0005164_abnormal_response_to | 1.09446171 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.09156511 |
| 57 | MP0002723_abnormal_immune_serum | 1.08483342 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.07998842 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.07152514 |
| 60 | MP0005409_darkened_coat_color | 1.05473451 |
| 61 | MP0001819_abnormal_immune_cell | 1.05206595 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.05071926 |
| 63 | MP0004858_abnormal_nervous_system | 1.04882859 |
| 64 | MP0002148_abnormal_hypersensitivity_rea | 1.04709242 |
| 65 | MP0001853_heart_inflammation | 1.03975970 |
| 66 | MP0003075_altered_response_to | 1.03092742 |
| 67 | MP0001216_abnormal_epidermal_layer | 1.01928602 |
| 68 | MP0002398_abnormal_bone_marrow | 1.00523053 |
| 69 | MP0002405_respiratory_system_inflammati | 1.00470959 |
| 70 | MP0005360_urolithiasis | 0.99361837 |
| 71 | MP0001845_abnormal_inflammatory_respons | 0.99031042 |
| 72 | MP0003045_fibrosis | 0.98138452 |
| 73 | MP0000003_abnormal_adipose_tissue | 0.97042593 |
| 74 | MP0003828_pulmonary_edema | 0.96801184 |
| 75 | MP0009278_abnormal_bone_marrow | 0.94226729 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.93725289 |
| 77 | MP0005365_abnormal_bile_salt | 0.93513726 |
| 78 | MP0001851_eye_inflammation | 0.92068239 |
| 79 | MP0000678_abnormal_parathyroid_gland | 0.91891409 |
| 80 | MP0005621_abnormal_cell_physiology | 0.91367005 |
| 81 | MP0003868_abnormal_feces_composition | 0.90932633 |
| 82 | MP0008469_abnormal_protein_level | 0.90228212 |
| 83 | MP0009931_abnormal_skin_appearance | 0.90053148 |
| 84 | MP0000609_abnormal_liver_physiology | 0.89781840 |
| 85 | MP0001666_abnormal_nutrient_absorption | 0.88952447 |
| 86 | MP0003329_amyloid_beta_deposits | 0.88913702 |
| 87 | MP0005501_abnormal_skin_physiology | 0.88851054 |
| 88 | MP0000716_abnormal_immune_system | 0.86751052 |
| 89 | MP0002429_abnormal_blood_cell | 0.86711993 |
| 90 | MP0003795_abnormal_bone_structure | 0.86036866 |
| 91 | MP0005165_increased_susceptibility_to | 0.85846851 |
| 92 | MP0003448_altered_tumor_morphology | 0.85725360 |
| 93 | MP0000604_amyloidosis | 0.84877913 |
| 94 | MP0001243_abnormal_dermal_layer | 0.84097746 |
| 95 | MP0005390_skeleton_phenotype | 0.83958069 |
| 96 | MP0002722_abnormal_immune_system | 0.83786602 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.78884275 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.78221960 |
| 99 | MP0002006_tumorigenesis | 0.78128260 |
| 100 | MP0001881_abnormal_mammary_gland | 0.77348063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 3.73369860 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.56548034 |
| 3 | Vertebral compression fractures (HP:0002953) | 3.46566890 |
| 4 | Deep venous thrombosis (HP:0002625) | 2.66457588 |
| 5 | Dysostosis multiplex (HP:0000943) | 2.56317331 |
| 6 | Abnormal gallbladder physiology (HP:0012438) | 2.43763036 |
| 7 | Cholecystitis (HP:0001082) | 2.43763036 |
| 8 | Increased connective tissue (HP:0009025) | 2.38305363 |
| 9 | Eczematoid dermatitis (HP:0000976) | 2.36044328 |
| 10 | Cervical subluxation (HP:0003308) | 2.33790027 |
| 11 | Fragile skin (HP:0001030) | 2.33339327 |
| 12 | Distal lower limb amyotrophy (HP:0008944) | 2.24236094 |
| 13 | Blue sclerae (HP:0000592) | 2.23596182 |
| 14 | Upper limb amyotrophy (HP:0009129) | 2.23418209 |
| 15 | Distal upper limb amyotrophy (HP:0007149) | 2.23418209 |
| 16 | Cerebral aneurysm (HP:0004944) | 2.22889984 |
| 17 | Increased variability in muscle fiber diameter (HP:0003557) | 2.22303974 |
| 18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.18659611 |
| 19 | Dilatation of the ascending aorta (HP:0005111) | 2.18617995 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.18528039 |
| 21 | Mucopolysacchariduria (HP:0008155) | 2.18528039 |
| 22 | Abnormality of the Achilles tendon (HP:0005109) | 2.17452927 |
| 23 | Osteolytic defects of the hand bones (HP:0009699) | 2.16178471 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16178471 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 2.15429820 |
| 26 | Distal lower limb muscle weakness (HP:0009053) | 2.15186231 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.14835081 |
| 28 | Achilles tendon contracture (HP:0001771) | 2.13544089 |
| 29 | Thin bony cortex (HP:0002753) | 2.13227167 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08885930 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08885930 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08885930 |
| 33 | Aneurysm (HP:0002617) | 2.08247021 |
| 34 | Broad face (HP:0000283) | 2.06861096 |
| 35 | Atrophic scars (HP:0001075) | 2.06658869 |
| 36 | Menorrhagia (HP:0000132) | 2.06389188 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.04659799 |
| 38 | Hyperacusis (HP:0010780) | 2.04551574 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.04492184 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04492184 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.04492184 |
| 42 | Polycythemia (HP:0001901) | 2.02677896 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.00758072 |
| 44 | J-shaped sella turcica (HP:0002680) | 1.98611479 |
| 45 | Myocardial infarction (HP:0001658) | 1.98111188 |
| 46 | Hypertensive crisis (HP:0100735) | 1.97588089 |
| 47 | Increased IgE level (HP:0003212) | 1.97566794 |
| 48 | Spinal rigidity (HP:0003306) | 1.97263308 |
| 49 | Ankle contracture (HP:0006466) | 1.96995836 |
| 50 | Fatigue (HP:0012378) | 1.96840429 |
| 51 | Wormian bones (HP:0002645) | 1.96706926 |
| 52 | Flat acetabular roof (HP:0003180) | 1.96164576 |
| 53 | Back pain (HP:0003418) | 1.94959443 |
| 54 | Spondylolisthesis (HP:0003302) | 1.94131584 |
| 55 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.94008125 |
| 56 | Loss of speech (HP:0002371) | 1.92505829 |
| 57 | Abnormality of complement system (HP:0005339) | 1.91220126 |
| 58 | Cellulitis (HP:0100658) | 1.90927362 |
| 59 | Hand muscle atrophy (HP:0009130) | 1.88064658 |
| 60 | Mitral stenosis (HP:0001718) | 1.87771216 |
| 61 | Aortic dissection (HP:0002647) | 1.86606532 |
| 62 | Abnormality of oral frenula (HP:0000190) | 1.85679184 |
| 63 | Aortic aneurysm (HP:0004942) | 1.84100242 |
| 64 | Ankyloglossia (HP:0010296) | 1.83062249 |
| 65 | Disproportionate tall stature (HP:0001519) | 1.82715522 |
| 66 | Vascular tortuosity (HP:0004948) | 1.82332882 |
| 67 | Short nail (HP:0001799) | 1.82017723 |
| 68 | Emphysema (HP:0002097) | 1.81297066 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81044601 |
| 70 | Abnormality of the common coagulation pathway (HP:0010990) | 1.80941119 |
| 71 | Biconcave vertebral bodies (HP:0004586) | 1.80119086 |
| 72 | Epistaxis (HP:0000421) | 1.79950735 |
| 73 | Purpura (HP:0000979) | 1.79585840 |
| 74 | Arterial tortuosity (HP:0005116) | 1.78897532 |
| 75 | Gingival bleeding (HP:0000225) | 1.78859998 |
| 76 | Systemic lupus erythematosus (HP:0002725) | 1.75584741 |
| 77 | Nonimmune hydrops fetalis (HP:0001790) | 1.72711285 |
| 78 | Peritonitis (HP:0002586) | 1.72362688 |
| 79 | Cardiovascular calcification (HP:0011915) | 1.70728273 |
| 80 | Impaired platelet aggregation (HP:0003540) | 1.70133208 |
| 81 | Abnormal platelet function (HP:0011869) | 1.70133208 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 1.69400100 |
| 83 | Increased serum ferritin (HP:0003281) | 1.69038619 |
| 84 | Exercise-induced myalgia (HP:0003738) | 1.69007954 |
| 85 | Xanthomatosis (HP:0000991) | 1.68051250 |
| 86 | Petechiae (HP:0000967) | 1.68028758 |
| 87 | Trismus (HP:0000211) | 1.67393342 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 1.66642631 |
| 89 | Long palpebral fissure (HP:0000637) | 1.66007643 |
| 90 | Reticulocytosis (HP:0001923) | 1.65375844 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 1.64395427 |
| 92 | Bladder diverticulum (HP:0000015) | 1.64290151 |
| 93 | Elbow flexion contracture (HP:0002987) | 1.62873468 |
| 94 | Bone pain (HP:0002653) | 1.62540008 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61930448 |
| 96 | Abnormality of the acetabulum (HP:0003170) | 1.61428734 |
| 97 | Vascular calcification (HP:0004934) | 1.60577447 |
| 98 | Orthostatic hypotension (HP:0001278) | 1.60258295 |
| 99 | Mitral regurgitation (HP:0001653) | 1.59954697 |
| 100 | Sparse lateral eyebrow (HP:0005338) | 1.59583724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.50127305 |
| 2 | TRIB3 | 3.81266758 |
| 3 | PRPF4B | 3.11275534 |
| 4 | IRAK3 | 2.79952505 |
| 5 | SIK1 | 2.48651904 |
| 6 | SMG1 | 2.46171340 |
| 7 | EEF2K | 2.08507899 |
| 8 | CDK12 | 2.04183001 |
| 9 | ICK | 2.01171531 |
| 10 | FGFR4 | 1.96994593 |
| 11 | EPHA2 | 1.91678227 |
| 12 | EPHB1 | 1.73232688 |
| 13 | MAP2K3 | 1.65053145 |
| 14 | RIPK4 | 1.58399018 |
| 15 | MAP3K13 | 1.58140999 |
| 16 | MST1R | 1.56676004 |
| 17 | MAP4K1 | 1.55949379 |
| 18 | MAP3K14 | 1.54582298 |
| 19 | NME2 | 1.53548851 |
| 20 | TYK2 | 1.53020659 |
| 21 | PAK4 | 1.48185088 |
| 22 | ZAP70 | 1.47463825 |
| 23 | TBK1 | 1.47291230 |
| 24 | TESK1 | 1.45833596 |
| 25 | PKN2 | 1.41944901 |
| 26 | TESK2 | 1.41752491 |
| 27 | MAP3K3 | 1.40296621 |
| 28 | SCYL2 | 1.38410506 |
| 29 | TTN | 1.36572175 |
| 30 | PDGFRA | 1.36312486 |
| 31 | RIPK1 | 1.33163168 |
| 32 | TAOK2 | 1.30481243 |
| 33 | IRAK4 | 1.23863541 |
| 34 | KSR2 | 1.22404841 |
| 35 | LMTK2 | 1.21337325 |
| 36 | ARAF | 1.19858109 |
| 37 | MAPKAPK3 | 1.10437061 |
| 38 | SIK3 | 1.10265266 |
| 39 | PRKD2 | 1.08898653 |
| 40 | MAP3K1 | 1.04293988 |
| 41 | EIF2AK1 | 1.02486248 |
| 42 | JAK3 | 1.02151195 |
| 43 | JAK1 | 1.00342783 |
| 44 | PTK2 | 0.98093963 |
| 45 | TRPM7 | 0.93675600 |
| 46 | CDC42BPA | 0.91278968 |
| 47 | MTOR | 0.89659102 |
| 48 | MAPK11 | 0.89586794 |
| 49 | PDPK1 | 0.84780100 |
| 50 | PTK6 | 0.83776702 |
| 51 | PIM2 | 0.82152756 |
| 52 | LRRK2 | 0.78205132 |
| 53 | GRK6 | 0.75750164 |
| 54 | HIPK2 | 0.74053490 |
| 55 | NEK9 | 0.71423992 |
| 56 | MAP3K11 | 0.71150738 |
| 57 | STK10 | 0.68674131 |
| 58 | MAP3K8 | 0.67564255 |
| 59 | MYLK | 0.67198930 |
| 60 | FGFR3 | 0.65880571 |
| 61 | TGFBR2 | 0.65826602 |
| 62 | CSK | 0.63642263 |
| 63 | MAP3K2 | 0.63097806 |
| 64 | BTK | 0.62960745 |
| 65 | BMX | 0.61885059 |
| 66 | ILK | 0.61766493 |
| 67 | MOS | 0.58153010 |
| 68 | TAOK1 | 0.55991731 |
| 69 | MARK2 | 0.55939134 |
| 70 | RPS6KB2 | 0.55053169 |
| 71 | PDK1 | 0.54194805 |
| 72 | HCK | 0.53574349 |
| 73 | MAPKAPK2 | 0.53199316 |
| 74 | IKBKE | 0.52519659 |
| 75 | IRAK2 | 0.50399791 |
| 76 | CDK4 | 0.49931121 |
| 77 | RET | 0.49771291 |
| 78 | CLK1 | 0.48980603 |
| 79 | CDK9 | 0.48903604 |
| 80 | MAP3K6 | 0.48600335 |
| 81 | PIK3CG | 0.48007148 |
| 82 | MET | 0.47673958 |
| 83 | JAK2 | 0.47256220 |
| 84 | RAF1 | 0.46783264 |
| 85 | PAK2 | 0.46669000 |
| 86 | PRKG2 | 0.45769482 |
| 87 | BLK | 0.45241150 |
| 88 | DDR2 | 0.44731218 |
| 89 | RPS6KA2 | 0.44107626 |
| 90 | CSF1R | 0.42501876 |
| 91 | PDGFRB | 0.41869104 |
| 92 | MAPK12 | 0.41826768 |
| 93 | MAP2K2 | 0.41663558 |
| 94 | IRAK1 | 0.40844981 |
| 95 | STK38 | 0.40436959 |
| 96 | CDK6 | 0.39933654 |
| 97 | IKBKB | 0.37728728 |
| 98 | NTRK1 | 0.37296747 |
| 99 | CDK7 | 0.35443621 |
| 100 | MAP3K10 | 0.34977430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.36010308 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.40004391 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.12178786 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.08413349 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.05866699 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98703980 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.84788762 |
| 8 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.63222157 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58865879 |
| 10 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.55575494 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.50599086 |
| 12 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50449146 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48996440 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40718683 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36539899 |
| 16 | Influenza A_Homo sapiens_hsa05164 | 1.36484364 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.34631971 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.34433003 |
| 19 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33682816 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32481538 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32168240 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31621829 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31255456 |
| 24 | Bladder cancer_Homo sapiens_hsa05219 | 1.30877373 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.30770093 |
| 26 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.26320596 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26080825 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26072448 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23493973 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.22612213 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.22531038 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.22381239 |
| 33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20973094 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18016431 |
| 35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.17317559 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16643790 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.14716586 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.11950844 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.11391394 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08982433 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.08544660 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04786631 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04060356 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02857045 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 1.01894690 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00850428 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.97872173 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97016376 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95286762 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.92297446 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91555865 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.87840311 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.86552037 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86464469 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86198881 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.86173344 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86043891 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85959052 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.85852720 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85224155 |
| 61 | Prostate cancer_Homo sapiens_hsa05215 | 0.84961623 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84911323 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84908002 |
| 64 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84254964 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83195792 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81257086 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.80684419 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80133017 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.79825007 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79529230 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78207643 |
| 72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76333875 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72745538 |
| 74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.71721315 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70814875 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70803919 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69985820 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69368294 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.68505715 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.68378665 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67967711 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67367070 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64819062 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.64102817 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.62365492 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59475398 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.57865396 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57106794 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56973800 |
| 90 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55936743 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55589887 |
| 92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55512380 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54522515 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53445170 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52255825 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52252793 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51912605 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51640280 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51507520 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50098838 |

